After a period characterized by uneven growth and strategic recalibrations in the wake of global health challenges, a key metric…
Read More

After a period characterized by uneven growth and strategic recalibrations in the wake of global health challenges, a key metric…
Read More
The pharmaceutical industry, after a period characterized by uneven growth and post-pandemic recalibration, is witnessing a significant upturn in R&D…
Read More